Cheeba Chews Delta 9 and CBC and CBD Salted Caramel Chews – Joint Relief (50 mg Total Cannabinoids)

CBC (cannabichromol) is a non-psychoactive phytocannabinoid found in cannabis that has attracted research interest for its anti-inflammatory and analgesic properties. Unlike THC which binds primarily to CB1 receptors, CBC interacts with TRPA1 (transient receptor potential ankyrin 1) and TRPV1 (vanilloid) receptors — receptor types involved in pain signalling, inflammation, and nociception. These pathways are particularly relevant to joint discomfort, inflammatory pain, and the kind of aching ease that Cheeba Chews' Joint Relief formula targets. At 10mg CBC per chew (double the 5mg THC dose), CBC is the primary active cannabinoid in the Joint Relief formula. The 6mg CBD per chew adds anti-inflammatory CB2 activity and anxiolytic support, while the 5mg THC provides the mild psychoactive ease that rounds out the entourage effect.

Standard CBD joint support products typically deliver cannabidiol alone or with minor amounts of other cannabinoids. Cheeba Chews Joint Relief adds two critical components that CBD-only products lack: 10mg CBC per chew for its direct TRPA1/TRPV1 anti-inflammatory action (a different mechanism than CBD's primarily CB2 receptor activity), and 5mg Delta-9 THC for psychoactive ease and analgesic properties through CB1 receptor engagement. The three-cannabinoid approach creates multiple simultaneous endocannabinoid system interactions — CB1 from THC, CB2 from CBD, and TRPA1/TRPV1 from CBC — that together address pain and inflammation through more pathways than any single cannabinoid can access. Cheeba Chews positions this as their most targeted formula specifically for physical comfort and joint-related discomfort.

Cheeba Chews recommends starting with one chew and waiting 60–90 minutes before determining whether you need more — effects can take up to 2 hours to fully develop. For consumers whose regular THC dose exceeds 5mg, taking a second chew (10mg D9 THC total) is reasonable after the full onset window has passed. The CBC and CBD components do not have the same psychoactive ceiling as THC, making additional doses of those cannabinoids less likely to produce overwhelming psychoactive effects — but the cumulative THC from multiple pieces should be considered carefully. For chronic daily joint management, one to two chews per session is a typical therapeutic approach, with the 10-chew package providing multiple days of supply.